Thieme E-Books & E-Journals -
Pharmacopsychiatry 2016; 49(04): 162-169
DOI: 10.1055/s-0042-101557
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients with Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study

Authors

  • M.-R. Nikbakhat*

    1   Department of Pharmacology, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
  • S. Arabzadeh*

    2   Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • A. Zeinoddini*

    2   Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Z. Khalili

    2   Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • F. Rezaei

    3   Qods Hospital, Kurdistan University of Medical Sciences, Sanandaj, Iran
  • P. Mohammadinejad

    2   Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • A. Ghaleiha

    4   Research Center for Behavioral Disorders and Substance Abuse, Hamadan University of Medical Sciences, Hamadan, Iran
  • S. Akhondzadeh

    2   Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran